DBV Technologies Announces Submission of Biologics License Application for Viaskin Peanut to the U.S. Food and Drug Administration
InMed Pharmaceuticals:Â Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value
Nextech3D.ai Announces CEO Evan Gappelberg Acquires 550,000 Shares of Company Stock In Open Market Buys